Anti-SARS-CoV-2 IgY

DB16356InvestigationalProtein Based Therapies

Anti-SARS-CoV-2 IgY are chicken egg antibodies to SARS-CoV-2 which have the potential to provide temporary protection against the virus when administered as intranasal drops. To create these antibodies, chickens are... To create these antibodies, chickens are injected in the chest with the spike protein, which is the surface protein of SARS-CoV-2; this results in an immune response mounted by the chickens towards the injected spike...

Also known as
Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY)
Code names
Anti-SARS-CoV-2 IgY

What you can answer from here — as of December 20, 2020

1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which companies are running trials of Anti-SARS-CoV-2 IgY, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account